Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Otsuka Corporation
  6. Summary
    4768   JP3188200004

OTSUKA CORPORATION

(4768)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
11/19/2021 11/22/2021 11/24/2021 11/25/2021 11/26/2021 Date
5460 5530 5410 5400 5360 Last
914900 646600 422200 258100 451700 Volume
+2.82% +1.28% -2.17% -0.18% -0.74% Change
Estimated financial data (e)
Sales 2021 875 B 7 721 M 7 721 M
Net income 2021 41 489 M 366 M 366 M
Net cash position 2021 192 B 1 699 M 1 699 M
P/E ratio 2021 24,5x
Yield 2021 2,28%
Sales 2022 917 B 8 096 M 8 096 M
Net income 2022 46 011 M 406 M 406 M
Net cash position 2022 211 B 1 863 M 1 863 M
P/E ratio 2022 22,1x
Yield 2022 2,44%
Capitalization 1 016 B 8 965 M 8 969 M
EV / Sales 2021 0,94x
EV / Sales 2022 0,88x
Nbr of Employees 9 119
Free-Float 57,7%
More Financials
Company
OTSUKA CORPORATION is a Japan-based company mainly engaged in the sale of system equipment, the installation support and maintenance services. The Company operates through two business segments. System Integration segment conducts consulting, hardware and software sales, contract software development, equipment installation and network construction. Service & Support segment provides office supply, maintenance... 
More about the company
Ratings of Otsuka Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about OTSUKA CORPORATION
11/19Nikkei rises on chipmakers, energy boost; SoftBank drops
RE
11/05GSK says anaemia drug shows positive safety profile
RE
11/01GlaxoSmithKline Rebuffs Reports on Potential Bid for Canada's Aurinia Pharmaceuticals
MT
10/29Akebia Says Partner Otsuka Files Initial MAA for Vadadustat with European Medicines Age..
MT
10/06LUPIN : Gets US FDA's Approval for Brexpiprazole Tablets
MT
10/04Sumitomo Dainippon Sells License for Psychiatry and Neurology Compounds to Otsuka for $..
MT
09/30Health Care Stocks Closing Slightly Lower After Early Gains
MT
09/30Health Care Stocks Unable to Sustain Early Rise
MT
09/30OPTIMIZERX : Hires Edward Stelmakh as CFO, COO
MT
08/30UNIVERSAL DISPLAY : Unit Adesis Appoints Linda Choi MacDonald as COO
MT
08/10NIKKEI 225 : Japanese Shares End Flat in Positive Territory on Trade Balance Data
MT
08/10Otsuka Holdings' Attributable Profit Rises 5.3% in January to June; Shares Jump 6%
MT
08/09Otsuka Q2 Earnings Gain; 2021 Outlook Boosted
MT
07/23MERIDIAN BIOSCIENCE : to Acquire Otsuka's North American BreathTek Business for $20 Millio..
MT
07/08NIKKEI 225 : Declines 0.9% on Pandemic, Federal Reserve Outlooks
MT
More news
News in other languages on OTSUKA CORPORATION
11/25Tokyo lâche 3% en séance face aux craintes autour du nouveau variant
11/24Tokyo plombée par la hausse des taux d'intérêt américains
11/01GlaxoSmithKline réfute les rapports sur une offre potentielle pour la société canadienn..
10/29Le partenaire d'Akebia, Otsuka, dépose une première AMM pour le vadadustat auprès de l'..
10/06Lupin obtient l'approbation de la FDA américaine pour les comprimés de Brexpiprazole
More news
Analyst Recommendations on OTSUKA CORPORATION
More recommendations
Chart OTSUKA CORPORATION
Duration : Period :
Otsuka Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OTSUKA CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 5 360,00 JPY
Average target price 6 065,38 JPY
Spread / Average Target 13,2%
EPS Revisions
Managers and Directors
Yuji Otsuka President, Representative Director & GM-Marketing
Minoru Sakurai Director & General Manager-Technology
Koichi Hisano Executive Officer & Manager-Compliance Office
Hironobu Saito Director, GM-Administration & Head-Audit Office
Jiro Makino Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
OTSUKA CORPORATION-1.65%8 965
VERISK ANALYTICS, INC.8.78%36 392
SAMSUNG SDS CO.,LTD.-15.97%9 695
REPLY S.P.A.73.03%6 968
CHANGE HEALTHCARE INC.11.15%6 457
CHINA TRANSINFO TECHNOLOGY CO., LTD-23.38%3 606